74
31.Perumal D, Dangor CM, Alcock RS, Hurbans N, Moopanar KR. Effect of
formulation variables on in vitro drug release and micromeritic properties of
modified release ibuprofen microspheres. J Microencapsul. 1999 Jul-
Aug;16(4):475-87.
32.Kjellqvist K. Reactive Acid Curing Waterborne Microparticles. Prog Org Coat.
1994 Jun-Sep;24(1-4):209-23.
33.Pignatello R, Bucolo C, Ferrara P, Maltese A, Puleo A, Puglisi G. Eudragit
RS100 (R) nanosuspensions for the ophthalmic controlled delivery of ibuprofen.
Eur J Pharm Sci. 2002 Jul;16(1-2):53-61.
34.Streubel A, Siepmann J, Bodmeier R. Floating microparticles based on low
density foam powder. Int J Pharm. 2002 Jul 25;241(2):279-92.
35.Giunchedi P, Juliano C, Gavini E, Cossu M, Sorrenti M. Formulation and in vivo
evaluation of chlorhexidine buccal tablets prepared using drug-loaded chitosan
microspheres. Eur J Pharm Biopharm. 2002 Mar;53(2):233-9.
36.Grattard N, Pernin M, Marty B, Roudaut G, Champion D, Le Meste M. Study of
release kinetics of small and high molecular weight substances dispersed into
spray-dried ethylcellulose microspheres. J Control Release. 2002 Dec
5;84(3):125-35.
37.Pariot N, Edwards-Levy F, Andry MC, Levy MC. Cross-linked beta-cyclodextrin
microcapsules: preparation and properties. Int J Pharm. 2000 Dec 15;211(1-2):19-
27.
38.Andry MC, Levy MC. In vitro degradation of serum albumin microcapsules:
Effect of process variables. Int J Pharm. 1997 Jun 26;152(2):145-51.
39.Payne RG, Yaszemski MJ, Yasko AW, Mikos AG. Development of an
injectable, in situ crosslinkable, degradable polymeric carrier for osteogenic cell
populations. Part 1. Encapsulation of marrow stromal osteoblasts in surface
crosslinked gelatin microparticles. Biomaterials. 2002 Nov;23(22):4359-71.
40.Payne RG, McGonigle JS, Yaszemski MJ, Yasko AW, Mikos AG. Development
of an injectable, in situ crosslinkable, degradable polymeric carrier for osteogenic
cell populations. Part 2. Viability of encapsulated marrow stromal osteoblasts